TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+8.42%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$113B
AUM Growth
+$6.09B
(+5.7%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
25.52%
Holding
1,445
New
84
Increased
613
Reduced
589
Closed
60
Top Buys
| 1 |
Apple
AAPL
|
$257M |
| 2 |
UnitedHealth
UNH
|
$226M |
| 3 |
Colgate-Palmolive
CL
|
$217M |
| 4 |
Moody's
MCO
|
$203M |
| 5 |
Curtiss-Wright
CW
|
$189M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$744M |
| 2 |
Lam Research
LRCX
|
$339M |
| 3 |
Merck
MRK
|
$305M |
| 4 |
Vistra
VST
|
$200M |
| 5 |
ConocoPhillips
COP
|
$181M |
Sector Composition
| 1 | Technology | 20.68% |
| 2 | Financials | 20.15% |
| 3 | Healthcare | 11.01% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Alto Neuroscience
ANRO
$104M
| $932K | ﹤0.01% |
76,992
-9,800
| -11% | -$119K |
|
1202
Lifestance Health
LFST
$2.17B
| $930K | ﹤0.01% |
133,938
+7,124
| +6% | +$49.4K |
|
1203
Black Diamond Therapeutics
BDTX
$171M
| $929K | ﹤0.01% |
219,678
-46,634
| -18% | -$197K |
|
1204
SPDR S&P Regional Banking ETF
KRE
$3.98B
| $922K | ﹤0.01% |
16,493
+2,319
| +16% | +$130K |
|
1205
Cadre Holdings
CDRE
$1.3B
| $917K | ﹤0.01% |
24,214
| – | – |
|
1206
Mercury Systems
MRCY
$4.1B
| $915K | ﹤0.01% |
+24,400
| New | +$915K |
|
1207
Houlihan Lokey
HLI
$14B
| $914K | ﹤0.01% |
5,800
-1,200
| -17% | -$189K |
|
1208
Axos Financial
AX
$5.16B
| $900K | ﹤0.01% |
+14,443
| New | +$900K |
|
1209
Lincoln Electric
LECO
$13.4B
| $897K | ﹤0.01% |
4,636
+152
| +3% | +$29.4K |
|
|
FLG
1210
Flagstar Financial, Inc.
FLG
$5.32B
| $884K | ﹤0.01% |
+77,168
| New | +$884K |
|
1211
Pliant Therapeutics
PLRX
$107M
| $883K | ﹤0.01% |
78,034
-34,214
| -30% | -$387K |
|
1212
Applied Therapeutics
APLT
$67.1M
| $882K | ﹤0.01% |
+106,600
| New | +$882K |
|
1213
Gossamer Bio
GOSS
$621M
| $880K | ﹤0.01% |
916,250
+274,752
| +43% | +$264K |
|
1214
Corbus Pharmaceuticals
CRBP
$120M
| $874K | ﹤0.01% |
41,800
+1,000
| +2% | +$20.9K |
|
1215
CareTrust REIT
CTRE
$7.68B
| $874K | ﹤0.01% |
+28,400
| New | +$874K |
|
1216
Insteel Industries
IIIN
$753M
| $871K | ﹤0.01% |
28,200
-18,300
| -39% | -$565K |
|
1217
ARS Pharmaceuticals
SPRY
$1.03B
| $862K | ﹤0.01% |
+60,200
| New | +$862K |
|
|
SLRN
1218
DELISTED
ACELYRIN
SLRN
| $860K | ﹤0.01% |
+174,380
| New | +$860K |
|
1219
Terns Pharmaceuticals
TERN
$633M
| $850K | ﹤0.01% |
+99,446
| New | +$850K |
|
1220
Urban Outfitters
URBN
$6.53B
| $847K | ﹤0.01% |
22,100
+5,100
| +30% | +$195K |
|
1221
EyePoint Pharmaceuticals
EYPT
$957M
| $837K | ﹤0.01% |
104,946
-22,748
| -18% | -$182K |
|
1222
Etsy
ETSY
$5.76B
| $836K | ﹤0.01% |
14,622
-107,921
| -88% | -$6.17M |
|
1223
Rivian
RIVN
$17B
| $828K | ﹤0.01% |
71,409
+377
| +0.5% | +$4.37K |
|
1224
Generation Bio
GBIO
$39.3M
| $828K | ﹤0.01% |
34,069
| – | – |
|
1225
Annexon
ANNX
$238M
| $821K | ﹤0.01% |
133,648
| – | – |
|